You are here

BCRF Grantee Since

2007

Donor Recognition

The Play for P.I.N.K. Award

Area(s) of Focus

Bruce G. Haffty, MD

Professor and Chairman, Department of Radiation Oncology
UMDNJ-Robert Wood Johnson Medical School
Associate Director,
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey

Current Research

Dr. Haffty’s laboratory is working to identify new therapeutic strategies to enhance radiation therapy and improve outcomes in women undergoing radiation for breast cancer. They previously reported that a protein called Bcl-2, which has been shown to promote the growth of breast cancer cells, is associated with resistance to radiation therapy. Combining drugs that target Bcl-2 with radiation significantly enhanced the effectiveness of radiation in laboratory models of breast cancer. They are working to understand the synergy between radiation and Bcl-2-targeted drugs and to find new ways to enhance the anti-tumor effects.

Bio

Bruce G. Haffty, MD is Professor and Chairman, Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School and New Jersey Medical School and Associate Director, Rutgers Cancer Institute of New Jersey. His medical school training, internship, residency and chief residency was at Yale.  Dr. Haffty was a Professor of Yale’s Department of Therapeutic Radiology, served as residency program director from 1992-2004, and Vice Chairman and Clinical Director from 2002-2005. He moved to the Robert Wood Johnson Medical School and Cancer Institute of New Jersey in 2005.

Dr. Haffty’s clinical area of expertise is breast cancer, and he has focused on outcomes and prognostic factors women undergoing radiation therapy, evaluating novel molecular markers and potential targets, for which he has had many research grants and conducted numerous clinical and translational research programs. He has published over 300 peer-reviewed articles and 30 book chapters. He is consistently listed as one of the country’s leading physicians by Best Doctors in America and Top Doctors in New York and New Jersey.  In addition to a busy clinical practice, Dr. Haffty has served on numerous national committees related to research and education in breast cancer and radiation oncology. He is currently an Associate Editor of the Journal of Clinical Oncology. Dr. Haffty is a Past President of the American Board of Radiology and the American Radium Society, past Chairman of the Residency Review Committee in Radiation Oncology, and the current President and incoming Chairman of the Board of the American Society for Radiation Oncology.